15.097 articles found

Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma.

Matsuo Y, Kamitani T.

PLoS One · 2010-05-05

DOI: 10.1371/journal.pone.0010481PMID: 20463956

Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation.

Du G, Liu X, Chen X, Song M, Yan Y, Jiao R, Wang CC.

Mol Biol Cell · 2010-05-05

DOI: 10.1091/mbc.e10-03-0200PMID: 20444973

Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).

Tijero B, Gomez-Esteban JC, Llorens V, Lezcano E, Gonzalez-Fernández MC, de Pancorbo MM, Ruiz-Martinez J, Cembellin JC, Zarranz JJ.

Clin Auton Res · 2010-05-05

DOI: 10.1007/s10286-010-0068-4PMID: 20443127

Screening of DNA aptamer which binds to α-synuclein

Tsukakoshi K, Harada R, Sode K, Ikebukuro K.

Biotechnology letters · 2010-05-01

Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.

Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, Chen ML, Lin CH, Mao XY, Chang XL, Prakash KM, Liu JJ, Au WL, Le WD, Jankovic J, Burgunder JM, Zhao Y, Wu RM.

Hum Mutat · 2010-05-01

DOI: 10.1002/humu.21225PMID: 20186690

Oligomeric alpha-synuclein and its role in neuronal death.

Brown DR.

IUBMB Life · 2010-05-01

DOI: 10.1002/iub.316PMID: 20209636

Two Parkinson's disease patients with alpha-synuclein gene duplication and rapid cognitive decline.

Shin CW, Kim HJ, Park SS, Kim SY, Kim JY, Jeon BS.

Mov Disord · 2010-05-01

DOI: 10.1002/mds.23043PMID: 20222138

Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells.

Pennington K, Peng J, Hung CC, Banks RE, Robinson PA.

J Proteome Res · 2010-05-01

DOI: 10.1021/pr901102dPMID: 20334438

Evidence for copper-dioxygen reactivity during alpha-synuclein fibril formation.

Lucas HR, Debeer S, Hong MS, Lee JC.

J Am Chem Soc · 2010-05-01

DOI: 10.1021/ja101756mPMID: 20423081

First appraisal of brain pathology owing to A30P mutant alpha-synuclein.

Seidel K, Schöls L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z, Dickson D, Gai WP, Bornemann A, Riess O, Rami A, Den Dunnen WF, Deller T, Rüb U, Krüger R.

Ann Neurol · 2010-05-01

DOI: 10.1002/ana.21966PMID: 20437567

Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.

Jowaed A, Schmitt I, Kaut O, Wüllner U.

J Neurosci · 2010-05-01

DOI: 10.1523/jneurosci.6119-09.2010PMID: 20445061

LRRK2 and Parkinson disease.

Dächsel JC, Farrer MJ.

Arch Neurol · 2010-05-01

DOI: 10.1001/archneurol.2010.79PMID: 20457952